Colorado Code § 23-21-1001

Medication for opioid use disorder - consultation - stipends - school of medicine duties - legislative declaration
Open in Lexace · Ask the AI about this section
(1) The general assembly finds and declares that:
(a) Many health-care providers who have completed the training required by the federal
drug enforcement agency and are eligible to provide medication for opioid use disorder are not
actively providing medication for opioid use disorder to patients who would benefit from this
medical service; and
(b) Practice consultation services consisting of follow-up training and support, including
stipends, can increase the number of health-care providers who prescribe medication for opioid
use disorder and the number of patients receiving medication for opioid use disorder.
(2) The university of Colorado school of medicine shall:
(a) Provide practice consultation services to health-care providers who are eligible to
provide medication for opioid use disorder. Practice consultation services must include:
(I) Staff training and workflow enhancement to encourage screening for opioid use
disorder and educational materials for patients who screen positive for opioid use disorder;
(II) Supporting the adoption of communication strategies that provide information to
patients and referral sources, including but not limited to emergency departments, emergency
medical service providers, hospitals, sheriffs departments, harm reduction organizations, and
faith-based organizations; and
(III) Providing access to marketing materials designed for patients and developed with
patient and practitioner input.
(b) Provide stipends to health-care providers who are eligible to provide medication for
opioid use disorder and who have achieved certain benchmarks known to lead to an increased
number of patients being managed by medication for opioid use disorder. At a minimum, the
benchmarks must include:
(I) Staff training and workflow enhancement to encourage screening and medication for
opioid use disorder induction for patients who screen positive for opioid use disorder;
(II) Adoption of marketing and communication strategies; and
(III) Documentation of having provided medication for opioid use disorder to at least ten
patients within a twelve-month period.
(3) Repealed.

‹ Prev All Colorado sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.